COMPANY NEWS & ANNOUNCEMENTS
Explore company announcements, partnerships, and milestones from across the Prognos story.
94 news articles
Company news archive
-1.png)
Lab Testing Insights, Quest, MAC
Discover how integrating Quest Diagnostics lab data with Prognos Health's insights enhances visibility and engagement for rare disease specialists, boosting targeting efficiency.
Read MoreLab Testing Insights, AI, Quest, HAE
Reducing the HAE diagnostic odyssey. Learn how Prognos Health leverages Quest Diagnostics data to help teams identify patients and improve access to care.
Read More
Lab Testing Insights, Commercial Launch Excellence, AI
AI can amplify insight, but harmonized lab data remains essential for grounded clinical signals and more effective healthcare targeting.
Read More
Lab Testing Insights, Lab Testing Trends, Rare Disease
Explore how real-world lab data can transform the commercial execution of early-stage Alzheimer's therapies by tracking biological changes in patients.
Read More.png)
Lab Testing Insights, Lab Testing Trends, Rare Disease
How lab data serves as a critical early warning system in diagnosing rare diseases, enabling quicker and more accurate identification and treatment. Learn why it's essential for pharma.
Read More
Lab Testing Insights, Commercial Launch Excellence, Rare Disease, Oncology, Field Force Effectiveness
Discover why aggregated EHR data often fails in precision medicine and learn the advantages of using direct-source, harmonized lab data for better outcomes.
Read More
Lab Testing Insights, Liquid Biopsy, Oncology, IHC
Emerging IHC markers like FOLR1, CLDN18.2, and cMET are now consistently adopted in routine testing, signaling a shift from theory to practice in community oncology.
Read More
Lab Testing Insights, Liquid Biopsy, Oncology, IHC
Discover the emerging protein biomarkers FOLR1, CLDN18.2, and cMET reshaping precision oncology and the importance of tracking their diagnostic adoption.
Read More
Commercial Launch Excellence, Lab Testing Trends, Patient Journey, Rare Disease
Discover how leveraging lab data can transform commercial strategies in Acute Lymphocytic Leukemia by providing insights throughout the patient journey.
Read More
Alerts, Commercial Launch Excellence, Lab Testing Trends, Patient Journey
Optimizing patient identification and management in Myelodysplastic Syndromes (MDS) through timely lab data.
Read More
Alerts, Commercial Launch Excellence, Lab Testing Trends, Patient Journey
Discover how leveraging lab data can transform commercial strategies in Acute Lymphocytic Leukemia by providing insights throughout the patient journey.
Read More%20(1).png)
Commercial Launch Excellence, Genomics Data, Oncology
Optimize oncology and genomics data licensing with seven best practices for high-quality, actionable lab data, for commercial impact. Download the free Lab Data RFP Template.
Read More
Lab Testing Insights
Join Prognos Health in observing Colorectal Cancer Awareness Month by understanding the importance of early screening, risk factors, and the evolving landscape of CRC therapies.
Read More
Lab Testing Insights
Explore the complexities of Chronic Kidney Disease, its varied patient experiences, and the importance of personalized care and early detection in managing this condition effectively.
Read More
Lab Testing Insights
Explore how leveraging lab data can help identify and profile key HCPs treating prostate cancer, enabling more targeted commercial outreach efforts.
Read More
Lab Testing Insights
Leveraging lab data for precise targeting in CLL treatment enhances patient outcomes and commercial strategies in a competitive landscape.
Read More
Lab Testing Insights
Prognos Health supports HAE commercial teams with lab data insights to improve patient diagnosis, treatment, and access to life-changing therapies.
Read More
Lab Testing Insights
Work with Prognos Health to leverage lab data to improve HCP engagement and patient outcomes in diagnosing and treating acromegaly.
Read More
Lab Testing Insights
Discover how leveraging lab data accelerates the identification of healthcare professionals treating acute myeloid leukemia.
Read More
Lab Testing Insights
How Prognos Health leverages real-world data to enhance precision targeting and optimize commercialization strategies for Lysosomal Storage Disorders.
Read More
Patient Journey, Breast Cancer, Oncology
Lab results generated throughout a patient's breast cancer journey represent a treasure trove of actionable data for pharmaceutical companies.
Read More
Alerts, Commercial Launch Excellence, HCP omnichannel marketing
Prognos Alerts is not merely a tool; it's a comprehensive solution designed to revolutionize the way you approach HCP engagement.
Read More
Rare Disease, Compliance, Sponsored Testing
The Department of Justice (DOJ) recently made waves with a ruling that significantly impacts how companies can conduct sponsored genetic testing.
Read More
Lab Testing Insights, NSCLC
Unlocking new insights in NSCLC treatment through extensive FISH panel data analysis. Personalized medicine is shaping the future of lung cancer therapy.
Read More
Alerts, Commercial Launch Excellence, Lab Testing Trends, Patient Journey
Liquid biopsies offer a game-changing opportunity for pharmaceutical companies to enhance their outreach to healthcare providers. Read to learn more.
Read More
Patient Journey, Conference
A common theme of the 2023 Digital Pharma East conference in Philadelphia, PA was patient first.
Read More.png)
Alerts, Omnichannel Marketing
Pharma brand teams are increasing their use of alerts in an effort to be more dynamic in their approaches to outreach.
Read More
RWD Marketplace, Rare Disease, Genomics Data
There are over 7,000 rare diseases, each affecting fewer than 200,000 people. Genomics data provides promise for shortening diagnosis.
Read More.jpg)
Conference, RWD Marketplace, ISPOR
It was no surprise to see that quality was a key theme at this year’s ISPOR conference
Read More.jpg)
Conference, Reuters Pharma, RWD Marketplace
Despite growth in the use of RWD, there were still plenty of challenges presented at Reuters Pharma 2023 that threaten to limit the value of this data.
Read More
Marketplace
The top 10 challenges faced by pharma professionals when gathering actionable data are solved by utilizing a RWD marketplace. Here’s how.
Read More
Alerts, Omnichannel Marketing
Without the proper support to know how, when, and where to reach HCPs, it can be challenging to achieve commercialization goals.
Read More
Marketplace
Leading pharmaceutical executives reveal 3 best practices for leveraging real-world data to target and engage with healthcare providers.
Read More
Marketplace
A new industry survey reveals the challenges that dominate current efforts around real world data in pharma and how to address them.
Read More
Healthcare costs are severely impacted by inflation. AI-driven risk prediction provides deeper member insight to help underwriters adjust.
Read More
Commercial Launch Excellence
Smaller pharmaceutical companies often lack the resources to successfully commercialize new therapies. An end-to-end RWD solution can help.
Read More
Patient Journey
Understanding the longitudinal patient journey takes time and money. See how Prognos data and analytics accelerate the process.
Read More
Event brings healthcare leaders together to discuss opportunities and challenges around the use of health data to improve patient outcomes.
Read More
Marketplace
Still buying entire data sources when securing patient medical data from a marketplace? See how you can start buying patient-centric data today.
Read More
5 ways the medical underwriting risk predictor solution jointly developed by Prognos Health and BHI can give you a distinct advantage.
Read More
Omnichannel Marketing
Fuel your pharma omnichannel marketing with this checklist that outlines 5 ways an RWD curation and analytics platform enhances outreach.
Read More
Predictive analytics in insurance underwriting requires an accurate snapshot of a prospective group’s healthcare to determine risk accurately.
Read More
A real world data platform can provide transformational benefits to life sciences. See how you can jumpstart adoption for your organization.
Read More
Marketplace
Choose the best marketplace for your real world data pharmaceutical launch and commercialization needs.
Read More
Marketplace
Learn how a healthcare data marketplace can transform and simplify patient-level real world data (RWD) buying.
Read More
AI
Prognos Health's Jason Bhan, M.D., and Adam Petranovich outline how AI & machine learning are used to add value to patient level RWD.
Read More
Disease Awareness
Identifying patients by their asthma phenotype can help you target your therapy and help the patients that need it most.
Read More
Marketplace
New bipartisan legislation could help accelerate the process of bringing new pharma products to market with real world health data insights.
Read More
Frequently used data sources for underwriting risk analysis and prediction scores can be incomplete, opening you up to financial losses.
Read More
Marketplace
The established standard for a real world data purchase is time-consuming and costly. We knew there had to be a better way. Learn more.
Read More
Commercial Launch Excellence
Our webinar on pharma product launch strategies for success featured lively debate with leaders from Novartis, Pfizer and Takeda. Learn more.
Read More
Alerts, Omnichannel Marketing
Clinical omnichannel data enables you to gain insights that identify when a provider is testing and treating for a given condition.
Read More
Lab Testing Insights
Recently, several new brands for the treatment of patients with mNSCLC targeting genetic abnormalities have been approved.
Read MoreOlivia Sborlini, Kent State graduate, spent the summer of 2020 as an Intern at Prognos Health. Learn about her experience!
Read More
Lab Testing Trends
For the week ending July 17, national lab testing volumes increased 21%. See the whole story on how testing trends have been impacted by COVID-19.
Read More
Lab Testing Trends
For the week ending July 10, national lab testing volumes dropped about 7% compared to the previous week. Learn why this may have happened.
Read More
Lab Testing Trends
Despite a holiday week, market trends in lab testing volumes remain at a high point. See the latest trends.
Read More
Lab Testing Trends
Market trends in lab testing volumes are continuing to grow week-over-week. See the latest lab testing trends, the impact from COVID, and the recovery.
Read More
Lab Testing Trends
Market trends in lab testing volumes are not only showing signs of recovery but overall growth. See the latest trends.
Read More
Lab Testing Trends
As the market trend has stabilized, see the latest trends and what we're seeing as signs of recovery in lab testing volumes.
Read More
Lab Testing Trends
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of COVID-19. See the latest trends.
Read MoreLab Testing Insights, Clinical
On May 20th, 2020, Jaclyn Fink presented to Women In Data's NYC Chapter on how clinical lab data is being analyzed.
Read More
Lab Testing Trends
Prognos is analyzing lab testing trends in 2020 looking at the impact of COVID-19 on testing trends at a national level through May 22.
Read More
Lab Testing Trends
Prognos is analyzing lab testing trends in 2020 to see the impact of COVID-19 on testing trends at a national level through May 15th.
Read More
Lab Testing Trends
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of COVID-19 on testing trends at a national level.
Read More
Lab Testing Trends
The pandemic has had a profound impact on healthcare. Prognos Health has been monitoring the impact COVID-19 has had on overall lab testing.
Read More
Omnichannel Marketing
Reaching the right audience, at the right time is the goal of sales and marketing, but it's never been more important for physician outreach.
Read More
Lab Testing Insights, Disease Awareness
The second blog in our 'Factor This' series featuring a Q&A with Prognos Health's Bill Bowman, Clinical Solutions Architect.
Read More
Blood Cancer, Disease Awareness, Blood Cancer Awareness Month
Some 14,000 people in the United States are diagnosed with Blood Cancer each month. Let’s throw everything we’ve got at this disease.
Read More
Disease Awareness
Awareness, prevention, and screening. Those are the objectives of World Lung Cancer Day, celebrated each August, and the shared goals of the
Read More
Lab Testing Insights
Read an interesting article by Jason Bhan, M.D., Chief Medical Officer of Prognos, here on on PM360.
Read More
Alerts, Disease Awareness
Awareness. Prevention. Education. Family. Those are the themes of Men’s Health Month, celebrated every June in the U.S. with screenings, health fairs,
Read More
Omnichannel Marketing
We’re excited to share part three of our blog series about one of the most promising methodologies for life science brands to harness: real world
Read More
Lab Testing Insights
As more targeted cancer therapies are developed, brand teams face an uphill battle in getting physicians to test for new biomarkers.
Read More
Lab Testing Insights, Omnichannel Marketing
What data sources are available for HCP omnichannel? This series explores the emerging arena where early adopters are synchronizing all promotion activity based on clinical diagnostic insights for competitive advantage.
Read More
Lab Testing Insights
By Bill Bowman, Clinical Solutions Architect The trend toward precision medicine in oncology is epitomized by the management of patients with metastatic
Read More
Disease Awareness
By Sanjiv Lall Every year we see new breakthroughs in medical science that allow us to treat, and sometimes even cure, diseases that were previously
Read More
Lab Testing Insights, digital, Omnichannel Marketing, HCP omnichannel marketing
What is HCP omnichannel for life sciences? This series explores the emerging arena where all promotion is synced based on clinical insights.
Read More
healthcare AI, AI, artificial intelligence
Researchers have been making significant advances in developing models to help convert data to an AI-friendly format. Prognos has found success in applying these models to converting data in healthcare.
Read More
AI
At the 2019 PMSA Winter Symposium, expert speakers and panelists shared deep insights with a focus on innovation, application, and collaboration.
Read More
Lab Testing Insights
Good data can make or break many healthcare organizations — including pharmaceutical companies. Anonymized lab data can help evaluate testing behavior, provide insights into patient outcomes, and demonstrate that treatments are working.
Read More
diabetes, Lab Testing Insights, diagnosis, HbA1c
Diabetes is one of many conditions where lab testing plays a critical role. Healthcare providers (HCPs) order lab testing, in general, for one of four reasons: to help diagnose a condition to determine which therapy would be most appropriate for a patient, to monitor disease control or progression, and to ensure that the patient is tolerating current therapy.
Read More
Lab Testing Insights
Rather than prescribing every cancer patient the same treatment regimen, oncologists and other interdisciplinary members of a patient’s care team are
Read More
As a life sciences brand manager, you are likely always looking to refine your sales and marketing strategies. You need to account for downward market
Read More
Lab Testing Insights, Disease Awareness
Why, how, and what might be next? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener If you’ve been following along with us through this series,
Read MoreLab Testing Insights, Disease Awareness
How is comorbidity affected by a double positive? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener> If you read our previous blog, you know
Read MoreLab Testing Insights, Disease Awareness
Is there an unidentified link between diabetes and RA? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener Diabetes and rheumatoid arthritis (RA)
Read MoreAI
Healthcare AI delivers actionable insights to pharma companies by recognizing key trends and patterns useful for finding population segments that would
Read MoreDisease Awareness
What Prognos Found and Where We'll Take It By Jason Bhan, MD, Fernando Schwartz, Brian Saindon, & Lauren Wiener Over the past few months, Prognos has
Read MoreDisease Awareness
Opening the Window of Opportunity for Pancreatic Cancer Screening By Jason Bhan, MD, Carol Smyth, MD, Fernando Schwartz, & Brian Saindon We are
Read MoreLab Testing Insights, Disease Awareness
Prognos Results: Part 1 By Carol Smyth, MD & Brian Saindon We’re back with our third blog in our pancreatic cancer series. In addition to
Read MoreLab Testing Insights, Disease Awareness, AI
The Prognos Study Method By Carol Smyth, MD & Brian Saindon Background About 80% of pancreatic cancers are found late, due to the lack of
Read MoreLab Testing Insights, Disease Awareness, AI
Pancreatic cancer is a devastating condition that can be just as hard to detect as it is to treat. Our findings may shed light on a patient’s journey.
Read MoreAI
More Thoughts from a Chief Data Scientist... Not all artificial intelligence is created equal. Some is optimized for playing poker, some - like Siri or
Read MoreTry a different keyword or year, or return to the full archive.
Get in touch with our team for questions and inquiries.